265 related articles for article (PubMed ID: 25003192)
1. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.
Lu Y; Liu X; Jiao Y; Xiong X; Wang E; Wang X; Zhang Z; Zhang H; Pan L; Guan Y; Cai D; Ning G; Li X
J Clin Invest; 2014 Aug; 124(8):3501-13. PubMed ID: 25003192
[TBL] [Abstract][Full Text] [Related]
2. Periostin: a new extracellular regulator of obesity-induced hepatosteatosis.
Wu T; Wu S; Ouyang G
Cell Metab; 2014 Oct; 20(4):562-4. PubMed ID: 25295785
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
[TBL] [Abstract][Full Text] [Related]
4. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
[TBL] [Abstract][Full Text] [Related]
5. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
[TBL] [Abstract][Full Text] [Related]
6. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
Li B; Zhang Z; Zhang H; Quan K; Lu Y; Cai D; Ning G
J Mol Endocrinol; 2014 Dec; 53(3):393-403. PubMed ID: 25312970
[TBL] [Abstract][Full Text] [Related]
7. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice.
Wan J; Shan Y; Song X; Chen S; Lu X; Jin J; Su Q; Liu B; Sun W; Li B
Mol Metab; 2020 Jan; 31():24-35. PubMed ID: 31918919
[TBL] [Abstract][Full Text] [Related]
9. Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Komatsu M; Kimura T; Yazaki M; Tanaka N; Yang Y; Nakajima T; Horiuchi A; Fang ZZ; Joshita S; Matsumoto A; Umemura T; Tanaka E; Gonzalez FJ; Ikeda S; Aoyama T
Biochim Biophys Acta; 2015 Mar; 1852(3):473-81. PubMed ID: 25533124
[TBL] [Abstract][Full Text] [Related]
10. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis.
Kobayashi T; Kanno K; Nguyen PT; Sugiyama A; Kawahara A; Otani Y; Kishikawa N; Ito M; Tazuma S
J Gastroenterol Hepatol; 2020 Dec; 35(12):2140-2150. PubMed ID: 32365405
[TBL] [Abstract][Full Text] [Related]
11. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
Stec DE; Gordon DM; Hipp JA; Hong S; Mitchell ZL; Franco NR; Robison JW; Anderson CD; Stec DF; Hinds TD
Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R733-R745. PubMed ID: 31483154
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.
Regué L; Minichiello L; Avruch J; Dai N
J Biol Chem; 2019 Aug; 294(31):11944-11951. PubMed ID: 31209109
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
14. The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits high-fat diet-induced hepatic steatosis via hepatic PPARα activation.
Shin SS; Yoon M
Pharm Biol; 2012 Oct; 50(10):1261-8. PubMed ID: 22870903
[TBL] [Abstract][Full Text] [Related]
15. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
16. Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.
Kulozik P; Jones A; Mattijssen F; Rose AJ; Reimann A; Strzoda D; Kleinsorg S; Raupp C; Kleinschmidt J; Müller-Decker K; Wahli W; Sticht C; Gretz N; von Loeffelholz C; Stockmann M; Pfeiffer A; Stöhr S; Dallinga-Thie GM; Nawroth PP; Diaz MB; Herzig S
Cell Metab; 2011 Apr; 13(4):389-400. PubMed ID: 21459324
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver.
Mooli RGR; Rodriguez J; Takahashi S; Solanki S; Gonzalez FJ; Ramakrishnan SK; Shah YM
Cell Mol Gastroenterol Hepatol; 2021; 12(2):585-597. PubMed ID: 33798787
[TBL] [Abstract][Full Text] [Related]
18. Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice.
Li J; Bi L; Hulke M; Li T
J Biol Chem; 2014 Aug; 289(32):22437-49. PubMed ID: 24986865
[TBL] [Abstract][Full Text] [Related]
19. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
[TBL] [Abstract][Full Text] [Related]
20. Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha.
Li G; Brocker CN; Yan T; Xie C; Krausz KW; Xiang R; Gonzalez FJ
Mol Metab; 2018 Jan; 7():80-89. PubMed ID: 29146411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]